S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Condition(s):LymphomaLast Updated:February 8, 2024Completed
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:February 8, 2024Completed
Condition(s):Follicular LymphomaLast Updated:December 1, 2023Recruiting
Condition(s):Non-Hodgkin’s LymphomaLast Updated:February 23, 2024Recruiting
Condition(s):Relapsed Lymphomas; Refractory LymphomasLast Updated:April 4, 2022Terminated
Condition(s):LymphomaLast Updated:December 2, 2021Completed
Condition(s):Indolent B-Cell LymphomasLast Updated:December 14, 2023Active, not recruiting
Condition(s):B Cell LymphomasLast Updated:March 23, 2021Withdrawn
Condition(s):Mantle Cell Lymphoma; B Cell LymphomaLast Updated:March 4, 2024Active, not recruiting
Condition(s):LymphomaLast Updated:September 21, 2023Recruiting
Condition(s):Lymphoma, B-Cell; Follicular LymphomaLast Updated:October 27, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.